Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by bligickaon Aug 07, 2020 8:55pm
97 Views
Post# 31381710

RE:RE:Thrm closes their pp

RE:RE:Thrm closes their pp Thrm did their pp as the price was rising....vxl tried to turn back the market cap in order to fufill their under priced over diluted pp .... Goren doesn't understand how the market works ...shareholders were getting slaughtered on the dilution, l for one was not happy with the way they priced the pp and the amount of shares involved...they destroyed the market momentum for the greedy pp and in the end couldn't pull it off .....probably tsx wouldn't approve......
luvhorses wrote: biglips,  you might be on to something here....he cancels the PP stating that in these trying times, financing is a problem....umm, in the ones  that I'm in,financing isn't an issue!  Different sector but we have a banker named Eric Sprott who has financed the ones that I'm in:  t.FVL, v.AVG, v.AMK (got back in it today), v.SPA, and v.DEC :)


<< Previous
Bullboard Posts
Next >>